134 related articles for article (PubMed ID: 16082250)
1. Nuclear beta-catenin expression is rare and its potential association with short survival in colorectal signet-ring cell carcinoma.
Wong SC; Chan AT; Lo ES; Lo YM
Appl Immunohistochem Mol Morphol; 2005 Sep; 13(3):248-51. PubMed ID: 16082250
[TBL] [Abstract][Full Text] [Related]
2. [Expression of CD10 in cancer-associated fibroblasts and its effect on initiation and progression of colorectal carcinoma].
Zhu Y; Zheng JJ; Yang F; Nie QQ; Zhu ZL; Deng H
Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):859-865. PubMed ID: 28056302
[No Abstract] [Full Text] [Related]
3. Distinct expression patterns of E-cadherin and beta-catenin in signet ring cell carcinoma components of primary pulmonary adenocarcinoma.
Moon KC; Cho SY; Lee HS; Jeon YK; Chung JH; Jung KC; Chung DH
Arch Pathol Lab Med; 2006 Sep; 130(9):1320-5. PubMed ID: 16948518
[TBL] [Abstract][Full Text] [Related]
4. Colorectal signet ring cell carcinoma: Influence of EGFR, E-cadherin and MMP-13 expression on clinicopathological features and prognosis.
Foda AAM; Aziz AA; Mohamed MA
Ann Diagn Pathol; 2018 Feb; 32():41-46. PubMed ID: 29414397
[TBL] [Abstract][Full Text] [Related]
5. [Expression and significance of APC, beta-catenin, C-myc, and Cyclin D1 proteins in colorectal carcinoma].
Dai WB; Ren ZP; Chen WL; DU J; Shi Z; Tang DY
Ai Zheng; 2007 Sep; 26(9):963-6. PubMed ID: 17927853
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and Molecular Characteristics of Colorectal Signet Ring Cell Carcinoma: A Review.
An Y; Zhou J; Lin G; Wu H; Cong L; Li Y; Qiu X; Shi W
Pathol Oncol Res; 2021; 27():1609859. PubMed ID: 34381313
[TBL] [Abstract][Full Text] [Related]
7. The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation.
Jung A; Schrauder M; Oswald U; Knoll C; Sellberg P; Palmqvist R; Niedobitek G; Brabletz T; Kirchner T
Am J Pathol; 2001 Nov; 159(5):1613-7. PubMed ID: 11696421
[TBL] [Abstract][Full Text] [Related]
8. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: III. Expressions of EMA, CEA, CA19-9, CDX-2, p53, Ki-67 antigen, TTF-1, vimentin, and p63 in normal mucosa and in 42 cases.
Terada T
Int J Clin Exp Pathol; 2013; 6(4):630-8. PubMed ID: 23573309
[TBL] [Abstract][Full Text] [Related]
9. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
10. β-Catenin and its relation to VEGF and cyclin D1 expression in pT3 rectosigmoid cancers.
Dılek FH; Topak N; Tokyol Ç; Akbulut G; Dılek ON
Turk J Gastroenterol; 2010 Dec; 21(4):365-71. PubMed ID: 21331989
[TBL] [Abstract][Full Text] [Related]
11. The Characteristics and Prognostic Effect of E-Cadherin Expression in Colorectal Signet Ring Cell Carcinoma.
Wang R; Ma X; Li Y; He Y; Huang D; Cai S; Peng J
PLoS One; 2016; 11(8):e0160527. PubMed ID: 27509205
[TBL] [Abstract][Full Text] [Related]
12. Signet ring cell carcinoma of resectable metastatic colorectal cancer has rare surgical value.
Fu J; Wu L; Jiang M; Tan Y; Li D; Chen F; Jiang T; Du J
J Surg Oncol; 2016 Dec; 114(8):1004-1008. PubMed ID: 27891617
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis.
Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H
Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500
[TBL] [Abstract][Full Text] [Related]
14. Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features.
Odajima T; Sasaki Y; Tanaka N; Kato-Mori Y; Asanuma H; Ikeda T; Satoh M; Hiratsuka H; Tokino T; Sawada N
Hum Pathol; 2005 Mar; 36(3):234-41. PubMed ID: 15791567
[TBL] [Abstract][Full Text] [Related]
15. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin.
Wang HL; Wang J; Xiao SY; Haydon R; Stoiber D; He TC; Bissonnette M; Hart J
Int J Cancer; 2002 Oct; 101(4):301-10. PubMed ID: 12209953
[TBL] [Abstract][Full Text] [Related]
16. Adenocarcinoma with mixed subtypes is a rare but aggressive histologic subtype in colorectal cancer.
Sheng H; Wei X; Mao M; He J; Luo T; Lu S; Zhou L; Huang Z; Yang A
BMC Cancer; 2019 Nov; 19(1):1071. PubMed ID: 31703713
[TBL] [Abstract][Full Text] [Related]
17. Expression of cell cycle markers in colorectal carcinoma: superiority of cyclin A as an indicator of poor prognosis.
Handa K; Yamakawa M; Takeda H; Kimura S; Takahashi T
Int J Cancer; 1999 Jun; 84(3):225-33. PubMed ID: 10371338
[TBL] [Abstract][Full Text] [Related]
18. A survival-stratification model of human colorectal carcinomas with beta-catenin and p27kip1.
Cheah PY; Choo PH; Yao J; Eu KW; Seow-Choen F
Cancer; 2002 Dec; 95(12):2479-86. PubMed ID: 12467060
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical staining of Reg IV and claudin-18 is useful in the diagnosis of gastrointestinal signet ring cell carcinoma.
Sentani K; Oue N; Tashiro T; Sakamoto N; Nishisaka T; Fukuhara T; Taniyama K; Matsuura H; Arihiro K; Ochiai A; Yasui W
Am J Surg Pathol; 2008 Aug; 32(8):1182-9. PubMed ID: 18580680
[TBL] [Abstract][Full Text] [Related]
20. Nuclear beta catenin as a potential prognostic and diagnostic marker in patients with colorectal cancer from Hong Kong.
Wong SC; Lo ES; Chan AK; Lee KC; Hsiao WL
Mol Pathol; 2003 Dec; 56(6):347-52. PubMed ID: 14645698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
